Published July 18, 2014 | Version v1
Journal article

The Fe-heme structure of met-indoleamine 2,3-dioxygenase-2 determined by X-ray absorption fine structure

  • 1. Institute of Materials Structure Science, KEK, Tsukuba, Ibaraki 305-0801 (Japan)
  • 2. Australian Synchrotron, Clayton, Victoria 3168 (Australia)
  • 3. School of Chemistry, The University of Sydney, NSW 2006 (Australia)
  • 4. Department of Pathology and Bosch Institute, The University of Sydney, Camperdown, NSW 2006 (Australia)

Description

Highlights: • IDO2 is a newly discovered tryptophan metabolising enzyme with a role in immunity. • IDO2’s active site contains a heme moiety for tryptophan binding and catabolism. • EXAFS/XANES analysis provides the first data of an IDO2 Fe-heme environment. • IDO2 Fe-heme exists as a low spin bis(His) form at 10 K; mixed spin-state at RT. - Abstract: Multiple-scattering (MS) analysis of EXAFS data on met-indoleamine 2,3-dioxygenase-2 (IDO2) and analysis of XANES have provided the first direct structural information about the axial donor ligands of the iron center for this recently discovered protein. At 10 K, it exists in a low-spin bis(His) form with Fe–Np(av) = 1.97 Å, the Fe–NIm bond lengths of 2.11 Å and 2.05 Å, which is in equilibrium with a high-spin form at room temperature. The bond distances in the low-spin form are consistent with other low-spin hemeproteins, as is the XANES spectrum, which is closer to that of the low-spin met-Lb than that of the high-spin met-Mb. The potential physiological role of this spin equilibrium is discussed

Availability note (English)

Available from http://dx.doi.org/10.1016/j.bbrc.2014.05.054

Additional details

Identifiers

DOI
10.1016/j.bbrc.2014.05.054;
PII
S0006-291X(14)00926-7;

Publishing Information

Journal Title
Biochemical and Biophysical Research Communications
Journal Volume
450
Journal Issue
1
Journal Page Range
p. 25-29
ISSN
0006-291X
CODEN
BBRCA9

Optional Information

Copyright
Copyright (c) 2014 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.